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EFFECTS OF THYMUS SIZE AND INVOLUTION ON THE CONTRIBUTION OF
RECENT THYMIC EMIGRANTS TO THE PERIPHERAL T CELL POOL
Michelle Lynn Bolner, B.S.
Supervisory professor: Ellen R. Richie, Ph.D.
The contribution of recent thymic emigrants (RTEs) to the peripheral naïve
T cell population is necessary to maintain diversity of the T cell receptor (TCR)
repertoire and produce immune responses against newly encountered antigens.
The thymus involutes with age, after irradiation or chemotherapy, and due to
severe viral infections. Thymus involution results in decreased thymopoiesis and
RTE output leading to a reduced diversity of peripheral T cells. This increases
susceptibility to disease and impairs immune responsiveness to vaccines.
Therefore, studies aimed at maintaining or regenerating thymic function are
integral for maintaining and restoring peripheral TCR diversity.
Mice that express a K5.CyclinD1 transgene expression have a severely
hyperplastic thymus that fails to undergo involution. Both thymocyte and TEC
development appear normal in these mice. We have used the K5.CyclinD1
transgenic model to test the hypothesis that preventing thymus involution will
sustain RTE output and incorporation into the peripheral T cell pool to prevent
naïve T cell depletion with age. The K5.CyclinD1 transgene was crossed to the
RAG2p-GFP transgenic model so that RTEs could be tracked by the intensity of
the GFP signal. The frequency and number of RTEs in naïve CD4 splenic T cells
was analyzed at monthly intervals to 5 months of age. Using this double
transgenic approach, we determined that preventing thymus involution does
maintain or enhance the number of RTEs in the peripheral T cell pool before and
after thymus involution.
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CHAPTER ONE: INTRODUCTION AND BACKGROUND

Chapter 1: Introduction
The immune system is indispensible for the protection of the body from foreign
insults. In 1961, Miller reported that thymectomy of newborn mice resulted in
decreased weight, systemic infection and death within weeks showing for the first time
that the thymus is necessary for production of defensive factors after birth (1, 2). Miller
also noted that antibody production was not affected in thymectomized mice, which led
to the hypothesis that cell-mediated immunity and cells capable of producing antibodies
were separate populations (3). T cells, so named for their development within the
thymus, convey cell-mediated immunity. This population mediates immunological
responses by direct cell-to-cell interactions. Each T cell clone possesses a unique and
highly specific T cell receptor (TCR) that is the product of multiple rearrangements
among TCRα and TCRb gene segments during development within the thymus. To
guard against autoreactivity and select for responsiveness, all developing T cells,
termed thymocytes, undergo an extensive screening process within the thymus by
interacting with epithelial cells. Once this program is complete, newly minted T cells
emigrate from the thymus to join the peripheral T cell pool encompassing an estimated
1012 unique TCR clones (4). Vast TCR diversity is necessary for generating an
immune response against almost any non-self antigen. Receptor diversity is
compromised with age by the substantial reduction of naïve T cell production as a
result of naturally occurring thymic atrophy (5). The decline in T cell output from the
thymus causes changes in the peripheral T cell pool, resulting in decreased immune
responsiveness to newly encountered antigens (6). This loss of affinity leads to poor
immune responses to vaccines and greater susceptibility to disease. Therefore,
understanding how to retain or regenerate a competent thymus in order to preserve
naive T cell output would provide a new insight to improving immune responses in
aging and immunocompromised individuals.
Thymus Organization
The thymus is a highly specialized organ of the immune system, tasked with
producing T cells that are both specific for foreign antigens and tolerant of selfantigens. In fact, nearly 98% of the cells within the thymus are thymocytes at various
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stages of T cell development. The remaining cells comprise the stromal
microenvironment and consist of primarily of thymic epithelial cells (TECs) but also
include dendritic cells, macrophages and endothelial cells (7). Structurally, the thymus
is organized into two distinct regions, each of which is required for T cell development.
The cortex is the outer region of the thymus, and is home to immature thymocytes and
cortical thymic epithelial cells (cTECs). The cTECs process and present self-peptides in
the context of major histocompatitbility (MHC) antigens required for positive selection
and release cytokines necessary for thymocyte survival and growth (8). The medulla is
the inner region of the thymus where semi-mature thymocytes and medullary thymic
epithelial cells (mTECs) interact. The mTEC subset is required for negative selection
because these cells have the unique ability to express a broad array of tissue restricted
antigens that can induce apoptosis of self reactive thymocytes (9). TECs and
thymocytes participate in an active crosstalk necessary for the survival of both cell
types. TECs provide survival, proliferative and differentiation signals necessary for
thymocyte maturation (10); without TEC interactions, thymocytes do not develop within
the thymus, as evidenced by the Foxn1-deficient nude mouse in which the failure of
TEC progenitors to differentiate abrogates T cell development (11). Similarly, TEC
differentiation depends on thymocyte-derived signals (12).
T Cell Development
Hematopoietic precursors migrate from the bone marrow through the circulation
to the thymus. It is difficult to identify thymus-seeding cells as they do not express any
known unique hematopoietic differentiation markers, only the hematopoietic stem cell
markers SCA1, and KIT (13). Thymus seeding cells enter the thymus through blood
vessels at the corticomedullary junction (CMJ), are not committed to the T cell lineage
and retain B cell potential. Expression of the ligand delta-like 4 on TECs initiates the
Notch pathway necessary for ensuing T cell development (14), along with pre-TCR
signaling. Thymocytes migrate from the CMJ through the cortex to the subcapsular
portion of the organ, and then back through to the medulla. During this process, they
interact with cTEC and mTEC subsets that provide signals for continued survival and
development. Four major thymocyte subsets are defined by the expression of CD4 and
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CD8 surface molecules during this process (Figure 1). The most immature thymocytes
are double negative (DN) for both CD4 and CD8 expression. The DN1 subset still
displays the lymphoid stem cell marker c-kit. The interleukin-2 receptor alpha chain
(CD25) is transiently expressed through the DN2 and DN3 stages in the cortex, while ckit expression is lost at the DN3 stage. TCRβ gene rearrangement is initiated at the
DN2 stage and the pre-TCR consisting of a TCRb and pre-Ta heterodimer is expressed
at DN3. Pre-TCR expression results in rescue from apoptosis, arrest of β chain gene
rearrangement, and a hyperproliferative burst during which CD25 expression is lost.
Expression of both CD4 and CD8 peptides indicates transition to the double positive
(DP) stage of thymocyte differentiation. The α chain of the TCR then rearranges to
create a viable αβTCR heterodimer. Only those cells that recognize self-peptides in
the context of self-MHC are stimulated to survive – most DP thymocytes will not
respond and thus fail positive selection and die from neglect. Positively selected
thymocytes down-regulate either CD4 or CD8, and commit to the T helper (CD4+) or
cytotoxic (CD8+) T cell lineages (15). These single positive (SP) thymocytes migrate
into the medulla where they undergo negative selection in which TCR affinity is tested.
Those that react with high affinity to self-antigen expressed by mTECs are deleted
while those that have a moderate affinity for self-peptide/MHC are exported to the
periphery. Only 2% of all DP thymocytes survive to the SP stage and are released as
naïve T cells to the periphery.
Thymic Emigration
Upon appropriate thymocyte development and selection in the thymus, newly
minted T cells emigrate through the vessels at the CMJ, and become recent thymic
emigrants (RTEs). Factors involved in emigration center around sphigosine-1phosphate receptor (S1P1), a G protein coupled receptor expressed by mature SP
thymocytes and shown to be integral in the exit strategy of a mature thymocyte from
the thymus. The ligand sphingosine-1-phosphate (S1P) is produced by pericytes along
the CMJ vessels, creating a chemotactic gradient by which the thymocytes home to the
vessels and exit the organ (16). The S1P1 receptor is positively regulated by the
transcription factor Kruppel-like factor 2 (KLF-2), and knockout studies have shown that
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Figure 1. Progression of normal thymocyte development. Thymus-seeding cells enter
the thymus and give rise to the double negative (DN) subset of developing thymocytes.
Upon TCR rearrangement, thymocytes express both CD4 andCD8 molecules and
become part of the double positive (DP) subset. DP thymocytes must lose surface
expression of either CD4 or CD8 to be deemed single positive (SP) thymocytes, before
preparing for export from the thymus.
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both are necessary components for T cell emigration from the thymus (16, 17).
Additionally, TCR engagement is a strong activator of the PI3K-AKT pathway and
results in nuclear export of FOXO1, a transcription factor that positively regulates KLF2
and thus, S1P1 (18). Therefore, studies suggest that TCR engagement inhibits KLF2
and S1P1 expression, which retains SP thymocytes in the thymus during the final
stages of maturation. Additionally, the C-type lectin CD69 is transiently upregulated in
response to TCR stimulation, and inhibits S1P1 expression by inducing internalization
of the protein (19, 20). These pathways of inhibition serve as an important checkpoint,
as TCR engagement ensures the retention of SP thymocyte by way of restriction S1P1
expression until proper maturation in the thymus is complete (18). Therefore, the TCR
influences the exit strategy of RTEs in such a way as to ensure only capable, mature
thymocytes are allowed exit to the peripheral T cell pool.
1.2 Recent Thymic Emigrants
The population of peripheral T cells is kept at a relatively constant number
throughout life by the constant addition of newly produced T cells from the thymus and
homeostatic control of peripheral T cell number. In general, peripheral T cells can be
classified as naïve T cells which have not yet encountered and undergone activation by
recognition of specific antigen, and memory cells which result from clonal expansion
and resolution after this recognition. Mature naïve (MN) T cells constitute the virgin T
cell population, and express low levels of self-reactivity, which is not enough to cause
autoimmunity, but necessary to ensure TCR sensitivity for foreign antigen.
Furthermore, the MN T cell population is maintained by MHC interactions and signaling
from the cytokine Interleukin-7 (IL-7). Upon antigen recognition, naïve T cells
proliferate and mount an immune response, with some cells remaining after infection
clearance to serve as memory T cells. Recent thymic emigrants (RTEs) are a distinct T
cell subset that sustains TCR diversity of naïve T cell repertoire through the addition of
unique TCRs to the population. Upon emigration from the thymus, RTEs are mature
with respect to thymocyte development, yet not fully capable of the functional maturity
of their MN T cell counterparts (21). Both CD4 and CD8 RTEs express distinct cell
surface phenotypes and altered functionality compared to the MN subset. RTEs exhibit
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reduced proliferation and production of cytokines IL-2, IL-4 and interferon gamma in
both man and mice compared to MN T cells (22). RTEs of newborn mice serve the
unique role of establishing the peripheral T cell pool, since there are few peripheral T
cells present at this age (23). These RTEs mature and give rise to the MN T cell
subset present after birth, and show that this population thrives in a lymphopenic
environment. However, thymic emigrants of the healthy adult enter a lymphoreplete
environment upon thymic exit, and must compete to share the same niche as MN and
memory T cells (24). While RTEs are capable of survival without exogenous factors for
several weeks, TCR signaling is essential for long-term survival (25). Many RTEs don’t
survive well in the periphery, and studies suggest that RTEs and naïve T cells compete
for MHC receptor and IL-7 interactions that mediate critical survival signals. RTEs
display a reduced affinity for these stimulators (26, 27), which is reflected in poor
incorporation into the naïve population (28). Cytokine signaling has been shown to
specifically play a role in reduced RTE survival – transgenic expression of the IL-7
receptor on RTEs rescues these cells from death and increases competitiveness with
MN T cells of the periphery (21).
The influx of the RTE population is necessary for enriching peripheral T cell
diversity, as successful viral clearance in mouse studies is enhanced by the presence
of RTEs in the peripheral T cell pool. In chronic viral infections, new naïve T cells
promote antigen-specific diversity and homeostatic proliferation that is lost in T cells
that have chronically responded (29). The preservation of antiviral CD8+ T cell
responses to infection is enhanced by the heterogeneity thymic emigrants contribute to
the naive T cell pool (30). Furthermore, individuals recovering from lymphopenia
induced from severe illness, HIV, and chemotherapeutics benefit from RTEs, which
reconstitute a diverse T cell repertoire. RTEs are clearly required to sustain immune
responsiveness to new antigens. Additional studies are required to determine precisely
how these cells mature and affect immunological responses.
Peripheral Maturity & Incorporation
In 1970, Stutman suggested that some type of additional developmental process
for naïve T cells in secondary organs might be necessary for final maturity to be
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achieved (31). To test this hypothesis, an intrathymic fluorescein isothiocyanate (FITC)
injection labeling method was designed to label all thymic cells and to identify RTEs.
After injection, FITC positive cells were observed in the spleen showing no phenotypic
difference from FITC negative cells for CD4 and CD8 expression, and suggesting that
RTEs do not undergo further maturation in the periphery (32). It was not until the use
of additional cell surface markers in conjunction with intrathymic FITC labeling that
differentiation between RTEs and naïve T cell were finally observed (33-35).
RTEs are mature in some aspects including CD4 and CD8 expression, yet not
others when compared to naïve T cells (35). RTEs are initially larger than their T cell
counterparts, and are functionally competent by 16 hrs in the periphery (32). RTEs lose
expression of Thy-1 and CD69 upon emigration. CD69 is an early activation antigen
that relies on TCR engagement for expression and suppresses thymic exit through
S1P1 inhibition (36-38). MHC class 1 molecules are commonly expressed at higher
levels on RTEs than MN T cells. Specifically, the MHC class Ib molecule, Qa2, is
upregulated as RTEs develop to mature naïve T cells in the periphery (34, 35). Family
members of Qa2 confer antiviral immunity to host defense when expressed on CD8+ T
cells (39). Analysis of cytokine receptor IL-7 receptor α (CD127) and co-stimulatory
molecule CD28, respectively, show increased expression with CD8+ RTE maturation
(40). Heat stable antigen (CD24) expression is decreased in a step-wise pattern from
RTE to naïve T cell, and is required for homeostatic proliferation on T cells in a
lymphopenic environment (41, 42).
Studies utilizing FITC labeling in conjunction with cell surface markers have
provided a foundation for RTE maturity analysis. However, crude intrathymic FITC
injections have been scrutinized for lack of specificity, with concerns regarding
contamination of the FITC positive population by recirculating MN T cells (43). By
repurposing a genetic mouse model created to examine B cell receptor editing for
thymic emigration studies, a faithful method of labeling SP thymocytes for export from
the thymus was achieved in a non-traumatic manner (44). Recombinant activating gene
2 (Rag2) promoter-driven GFP expression allows for tagging of late stage DN
thymocytes. The Rag2 gene is required for α and β TCR gene rearrangement, and
after which its expression is extinguished (40). This transgenic model allows precise
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aging of T cells released from the thymus, with the gradual loss of GFP signal used as
a molecular timer within RTEs in the periphery. Since GFP half-life is 16-18 hours (40,
45), and GFP signal is completely lost within three weeks in the periphery (40),
peripheral naïve T cells can be divided into three separate populations (Figure 2).
Those cells that exhibit high GFP intensity (GFPhigh), have been in the periphery less
than one week according to kinetic studies (40), while those that express low GFP
intensity (GFPlow) have resided in the periphery for 1-3 weeks. Those that are negative
for GFP expression (GFPneg) are considered MN T cells. Additionally, GFP expression
in RTEs does not alter development nor proliferative capability in these cells (40). Thus,
the naïve T cell population can be studied in unmanipulated mice bearing the Rag2pGFP transgene, with the separation of new naïve T cells by the amount of time spent in
the periphery. This transgenic model, coupled with analysis of cell surface markers has
defined a reproducible method of chronicling the maturation of RTEs to functionally
competent naïve T cells in the periphery (40, 46). By beauty of the system, thymic
emigration can be studied at any age in the mouse, provided there is sufficient
thymopoiesis occurring to produce RTEs.
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Figure 2. GFP intensity in the RAG2p-GFP model can be used as a molecular timer for
RTEs. GFP is expressed during TCR gene rearrangement and is extinguished by the
single positive (SP) stage. GFP expression is lost due to proliferation and protein
decay. GFP expression is completely lost by 3 weeks in the periphery.
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1.3 Thymic Growth and Involution
The thymus originates from the third pharyngeal pouch of the developing mouse
embryo. At embryonic day 11.5 (E11.5) the third pouch is divided into thymic fated and
parathyroid fated domains. The thymic domain can be distinguished by expression of
Foxn1, a transcription factor required for TEC development and maintenance (47, 48).
Thymic size is largest in children, and peaks at 4-6 weeks of age in the mouse (49,50).
Thymic output is also greatest early in life, with RTEs accounting for almost 20% of the
total T cell population in mice at six weeks of age (51). Thymus homeostasis is
achieved for a short period in young mice as defined by relatively constant cellularity.
(7). With age the thymus undergoes progressive involution due primarily to loss of
TECs and disintegration of the TEC network required to support thymocyte
development. Phenotypic characterization of involution includes disorganization of the
stromal compartments, increased fibroblastic populations (7, 52) and accumulation of
adipocytes in the tissue (53). As a result of thymus involution, there is a decline in
thymopoiesis and naïve T cell output. Involution also occurs independent of age, as a
result of cytoablative therapy and after severe viral infections (54).
Effects of Involution on the RTE population
The thymus is still functional in aged mice as shown by the production of RTEs
in mice two years of age. The ratio of thymocytes to RTEs is not affected with age, and
is independent of involution (51). However due to the overall decline in thymopoiesis,
the number of RTEs exported to the periphery decreases up to 30-fold (51). This loss in
RTE output leads to a loss of TCR diversity, as the ability to produce T cells with
unique affinities is significantly compromised with age. Additionally, production of naïve
T cells with defects in cell surface molecule expression and delayed maturation kinetics
occurs in old mice (50, 51). Proportions of developing thymocytes do not change in
murine thymi as old as 18 months of age, yet the expression of surface molecules are
altered. CD3 expression is significantly reduced upon new naïve T cells, and normal
down-regulation of CD24 is delayed (55). Responses to mitogen stimulation is also
impaired – diminished TCR activation has been observed (51) and the expression of
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co-stimulatory molecule CD28 is dampened upon human CD8 T cells in the elderly.
Furthermore, activation associated IL-2 secretion is dampened in RTEs of aged mice
compared to naïve T cells in the periphery (51). These studies together suggest that
naïve T cells derived from involuted thymi are already functionally impaired, adding to
the reduced T cell response in the aged.
The peripheral pool cellularity is maintained despite thymic involution, due to
tight homeostatic maintenance of T cell populations. There is a shift in the ratio
between peripheral populations that is correlated with involution. As the number of
RTEs declines with age, the reduction in naïve T cell number prompts clonal expansion
of the memory T cell compartment to maintain homeostasis (56). The contraction of the
naïve T cell pool has been observed in both humans and rodents with age, and
compromises T cell diversity for both CD4 and CD8 T cell populations. Clonal
expansion of cells in the memory compartment is responsible for the reduction of 108
clones in young adults to 106 clones in elderly humans and has been correlated to the
reduced ability to mount a successful immune response, particularly to new antigens
(57). Additionally, function of old naïve T cells is affected with age. Old CD4 naïve T
cells exhibit diminished responses to T cell receptor stimulation, and produce aberrant
cytokine secretion compared to naïve T cells from young mice (57). There is an
increase in pro-inflammatory CD8 T cells in the elderly, which impedes longevity (58).
Low naïve precursor frequency is seen in activated CD8 T cells in aged mice and leads
a reduced response of T cells and holes in the repertoire (59). Taken together,
decreased RTE production leads to aging in the peripheral T cell pool which results in
reduced immune responses in old age.
Prevention of thymic involution and reduced RTE production
The crux of involution and aging studies is to understand the process of
involution in order to be able to slow, stop, or reverse thymic involution in aging and
immunocompromised patients. Studies focused on androgen ablation have shown that
thymic rebound occurs in a transient manner in the aged human and mouse, and T cell
output is enhanced upon return of thymic size (60, 61). TECs have been implicated in
the degeneration of the thymic environment. Foxn1 is integral in initial thymic
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development and maintenance. Foxn1 / mice, which are a hypomorphic variant that
Δ Δ

results in reduced thymic size, produce TECs which are blocked at an intermediate
differentiation stage, and results in blocked α:βT cell production (62). Inducible Foxn1
studies in which Foxn1 expression is targeted to the thymic epithelium after involution
suggest that TEC progenitors exist even in aged thymi, and can give rise to this
expansion of thymic tissue and maintenance of developing thymocyte numbers (63, C
Blackburn, personal communication). Meanwhile, knocking out cell cycle inhibitor
proteins like the retinoblastoma (RB) family members in TECs in an inducible fashion
can achieve sustained thymic rebound in mice up to nine months of age (J Sage,
personal correspondence). However, induction of this phenotype in older mice has not
been possible, suggesting age restraints RB-mediated thymic rebound. These studies
together show that there is not only a potential for thymic regrowth in aged individuals,
but also that T cell output can be positively affected too. However, these studies only
accomplish rebound that is transient, or cannot be achieved after a certain age, barring
continued T cell output in old age. Furthermore, recent speculation suggests issues
with the quality of T cells produced by means of thymic rebound. Age-associated
changes including medullary islet complexity and decreased levels of tissue restricted
antigens are found in rebounded thymi (64). This new report questions the feasibility of
thymic regeneration if quality of the thymic emigrants is compromised.
Cyclin D1 is a key cell cycle regulator that activates cdk4 and cdk6 to promote
cell cycle progression and also functions in a cdk-independent manner as a
transcriptional regulator. Our lab has shown that expression of a Cyclin D1 transgene
targeted to epithelial cells by a keratin 5 (K5) promoter results in a hyperplastic thymus
that does not undergo involution (65, 66), yet no hyperplasia of the lymphoid organs is
observed (Figure 3). Despite the severe thymus hyperplasia in K5.CyclinD1 mice,
cortical and medullary organization are preserved (66). Furthermore, the
corticomedullary junction is expanded, and it thought to enhance both TEC and
thymocyte development, as this region has been implicated in harboring TEC precursor
populations (12). Thymocytes develop normally according to phenotypic analysis,
though absolute numbers of the major thymocyte subsets are much greater than in
non-transgenic littermates (66). Therefore, the K5.CyclinD1 mouse model provides an
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Figure 3 - K5.CyclinD1 thymi develop severe thymic hyperplasia. Thymic and spleen
cellularity was taken at 4 and 24 weeks of age from K5.CyclinD1 and nontransgenic
littermates. Thymic hyperplasia increases with age, and does not undergo involution.
Splenic cellularity is not affected by thymic hyperplasia.
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opportunity to study thymic structure and T cell production independent of thymic
involution. Determining the alterations made to the peripheral T cell pool by continued
production of RTEs, as well as RTE maturity in this model with age will give insight to
the idea that continued T cell production and diversity in elderly patients would prevent
health issues from infectious agents.
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Chapter 2: Materials and Methods
Mice
K5.CyclinD1 transgenic breeders were originally provided by C. Conti (MD
Anderson Cancer Center, Science Park Research Division, Smithville, Texas) and
maintained on the C57BL/6J background. RAG2p-GFP transgenic breeders were
purchased from The Jackson Laboratory (Bar Harbor, Maine) on the FVB background
and bred with the K5.CyclinD1 model. PCR was utilized to determine K5.CyclinD1 and
Rag2p-GFP transgene expression, and visually confirmed upon dissection. All mice
were maintained in pathogen-free conditions, and experiments were performed in
accordance with all MD Anderson Institutional Animal Care and Use Committee
policies.
H&E and Immunohistochemistry
Hematoxylin and eosin (H&E) staining was performed on frozen sections at 5um
thickness. Staining was performed as follows: Slides were thawed to ambient
temperature for 30 minutes, and fixed using 10% neutral buffered formaldyhyde. Slides
were treated with hematoxylin (Fischer) for 3-10 minutes, and rinsed gently under tap
water. Slides were then treated with 1% stock eosin (Sigma) for 3-10 minutes, and
again rinsed gently under tap water. Slides were dehydrated through a quick series of
ethanol dips as follows: 70%, 90%, 96% and 100%. Slides were rinsed in xylene
(Fischer) twice for a total of ten minutes. Finally, slides were coverslipped with cytoseal
(ThermoScientific).
Immunohistochemistry was performed using frozen sections as follows: Slides
were allowed to thaw to ambient temperature for 30 minutes. Slides were fixed in room
temperature acetone for 5 minutes, and washed in three 5-minute rinses of TNT
(Perkin Elmer). Slides were blocked with TNB block provided in TSA kit (Perkin Elmer).
Primary antibodies were added to slides for 1-8 hours at room temperature, and rinsed
by three 5-minute rinses with TNT. Secondary antibody was diluted at 1ug/300ul TNB
and applied for 30 minutes, and rinsed by 3 5-minute TNT rinses. Sections were
treated with DAPI (Vector Labs) at a concentration of 1ul:1500ul ddH20 for three
minutes, rinsed a final time for 5 minutes in TNT, treated with VectaShield (Vector labs)
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mounting medium, and coverslipped. The following primary antibodies were used: K5
(Covance), K8 (Troma-1, gifted from N. Manley), K14 (Covance), UEA-1 (Vector).
Secondary antibodies were donkey-anti-rat-Texas-Red (Jackson) and donkey-antirabbit-FITC (Jackson).
Preparation of Tissue for TEC FACS analysis
Thimi were dissected and prepared according to the protocol from Grey et al
(67). Thymi were removed and washed in cold, sterile 1x PBS (Hyclone). Thymus
lobes were trimmed of connective tissues and fat, separated, and the capsule nicked
with scissors. Thymi were digested in 0.125% Collagenase (Sigma), 0.1% DNAse1
(Roche) for 30 minutes at 37°C in a bacterial shaker, and supernatant was removed
and stored on ice and freshed collagenase readded every ten minutes. Tissue was
then digested in 0.125% Collagenase/Dispase (Roche), 0.1% DNAse1 for an additional
10-20 minutes at 37°C in a bacterial shaker. Any remaining clumps of tissue were
disrupted mechanically using a glass pipette. All cells from the same initial thymus
were pooled in a 50ml conical tube (BD Falcon). Conical tubes were centrifuged at
1500rpm for 3 minutes to pellet cells, supernatant was removed and cells were
resuspended in cold, sterile FACS Wash Buffer to a volume of 10ml. Cell preparations
were counted using a trypan blue viability stain (Invitrogen) and a Countess®
automated cell counter (Invitrogen). Cells were distributed at 3 million cells per FACs
polystyrene tube (BD Falcon) in a volume of 300ul of PBS for antibody staining.
Preparation of Tissue for thymocyte FACS Analysis
Thymi and spleens were removed and washed in cold, sterile 1x PBS (Hyclone).
Tissues were trimmed of connective tissues and fat, and pressed through a 70-micron
mesh screen (Fisher) using the plunger end of a 1ml syringe (BD Falcon). Strainers
and tissue were washed with PBS and collected in a 50ml conical tube (BD Falcon).
Conical tubes were centrifuged at 1500rpm for 5 minutes to pellet cells, and
resuspended in cold, sterile PBS to a volume of 10ml. Splenic samples were treated
with red blood cell lysis buffer (0.002% Tris, 0.0086%NH4Cl w/v) and washed with PBS.
Red blood cell lysis buffer-treated samples were centrifuged again and resuspended in
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10ml of cold, sterile PBS. Both thymic and splenic cell preparations were counted
using a trypan blue viability stain (Invitrogen) and a Countess® automated cell counter
(Invitrogen). Cells were distributed at 3 million cells per FACs polystyrene tube (BD
Falcon) in a volume of 300ul of PBS for antibody staining.
Organ Weights and Cellularity
Thymi and spleens obtained for FACS analysis or from dissection were trimmed of
connective tissues and fat, and rinsed in cold, sterile PBS. Weights were obtained in
measured PBS, on an electronic scale (APX-602, Denver Instrument). Total body
weight was taken before dissection, post mortem.
Antibodies used for FACS Analysis
Thymic and splenic cells were stained with the following primary antibodies: anti-CD4Pacific Orange (Invitrogen), anti-CD8-PE/Cy7 (eBioscience), anti-CD24-PerCP/Cy5.5
(eBioscience), anti-CD25-Pacific Blue (BioLegend), anti-CD44-APC (eBioscience), antiCD45-PerCP/Cy5.5 (eBioscience), anti-CD62L-Biotin (eBioscience) or anti-CD62LAlexafluor 700 (eBioscience), anti-CD69-PE (BioLegend), anti-CD127-Biotin
(eBioscience) or anti-CD127-APC efluor 780 (eBioscience), anti-IA/IE-Pacific Blue
(Biolegend), anti-UEA1-FITC (Vector), anti-Ly51-Biotin (BD Pharmingen), anti-TER119PE/Cy5 (eBioscience), anti-Qa-2-Biotin (BD Biosciences), anti-Mouse IgG2a,k-Biotin
(BD Biosciences). Primary antibodies were added to 3 million cells in 300ul PBS for 15
minutes in the dark, and washed with cold PBS. Samples were centrifuged at 1500rpm
for 3 minutes to form cell pellets, and resuspended in 300ul of PBS. Secondary
antibody was added if necessary, and SA-Qdot 605 (Invitrogen) was used. Secondary
incubation was performed for 15 minutes in the dark, and samples were centrifuged at
1500rpm for 3 minutes to pellet cells. All samples were brought to a volume of 500ul in
PBS for FACS analysis using the AriaIIu® cell sorter (BD Biosciences). Analysis for
data acquired from FACs was analyzed using the FlowJo (Version 9.4.10) program by
Treestar (Ashland, Oregon).
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Sorting and qRT-PCR
Cells prepared by TEC FACS method (See above) were sorted on a FACS AriaIIu®
cell sorter (BD Biosciences) into MHCII+CD45- or MHCII-CD45+ separate populations
directly in to TriZol (Invitrogen) RNA reagent, and stored at -80°C. All samples were
prepared and qRT-PCR performed by the Molecular Biology Core at MDACC Science
Park, Smithville, Texas.
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CHAPTER THREE: RESULTS

	
  

21	
  

Chapter 3: Results
Thymus Phenotype in K5.Cyclin D1 mice on a C57Bl/6J background
Although the molecular mechanisms that regulate thymus size and homeostasis
are not well defined, it is clear that genetic background is influential (68). Robles et al.
reported that the K5.Cyclin D1 transgene produced a severe hyperplastic thymic
phenotype that resulted in respiratory distress by twenty weeks of age in mice on a
FVB background (65). Since most immunological research is performed in a C57Bl/6J
background, we backcrossed K5.Cyclin D1 transgenic mice onto a C57Bl/6J
background (F>7 generations). Our initial goal was to determine if the thymus
phenotype observed in the original report describing K5.CyclinD1 mice was preserved
after crossing the transgene onto a C57Bl/6J background. As in the original report, the
K5.CyclinD1 transgenic mice developed hyperplastic thymi that failed to undergo
involution with age in contrast to their nontransgenic littermates (Figure 3). We also
noted that similar to earlier reports (12, 66), there was only a modest increase in the
number of spleen cells in transgenic mice compared to control mice.
In order to analyze thymic architecture in transgenic and control mice, H&E
stained frozen sections (Figure 4 A,B) were compared. The medulla and cortex were
well defined in the K5.CyclinD1 thymus, with proper delineation between the two
compartments. Because H&E stained thymic sections mainly reveal the thymocyte
organization within the thymus, immunohistochemistry was performed to analyze
stromal organization and maturation. Epithelial cell differentiation is characterized by
expression of various keratin (K) markers. In the thymus K5 and K8 were used to
distinguish cTEC and mTEC subsets, respectively. We found that 4 week old
K5.CyclinD1 transgenic and littermate control thymi contained comparable K5-K8+
cTEC and K5+K8- mTEC subsets (Figure 4 C,D). Furthermore, normal expression of
the additional cTEC markers CD205 and Ly51 was observed (data not shown). We
also analyzed serial sections for expression of K14, a heterodimer binding partner of
K5, and binding of the lectin Ulex europeaus agglutinin-1 (UEA-1). These two markers
identify
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Figure 4. Thymic architecture is intact in the K5.CyclinD1 model.
H&E staining of 4 week frozen thymus sections shows well defined cortex and medulla
in nontransgeneic (A) and K5.CyclinD1 (B) thymi. (C-D) IHC staining of 4 week frozen
sections; K5 (red); K8 (green). Serial slides stained for K14 (red); UEA-1 (green).
Distinct mTEC (K8-K5+) and cTEC (K8+K5-) subsets in control (C) and K5.D1 (D) thymi.
IHC staining of 25 week frozen sections (G-J), with arrows showing expansion of
K5+K8+ TECs in K5.D1 thymus. (G) K14 (red) and UEA-1 (green) mTEC subsets.
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distinct mTEC subsets (Figure 4 E,F). As in nontransgenic mice, the medullary regions
of K5.CyclinD1 transgenic mice contained a major subset of K5+K14+ TECs. At 25
weeks of age, however, a distinct subset that did not express K5 or K14, but that binds
UEA-1 was observed. These data suggest that K5.CyclinD1 transgenic thymi develop
TEC subsets that have typical differentiation markers and are properly localized in
cortical and medullary regions. However, as previously reported (12), I noted an
expanded K8+K5+ subset at the CMJ in K5.CyclinD1 thymi that did not co-express K14
at 25 weeks of age (note yellow ‘halo’ staining in Figure 4H). We and others have
suggested that TEC progenitors reside in this subset (66, 69). These findings imply that
the thymus hyperplasia may be due to expansion and/or maintenance of TEC
precursors that generate microenvironmental niches that, in turn, support thymocyte
development.
Expression of Cyclin D1 is driven by the epithelial-specific K5 promoter resulting
in expression of Cyclin D1 in TECs and a profound thymic phenotype. However, the
effects of this overexpression on development and maintenance of the TEC
compartment have been largely unstudied. To analyze TEC composition, single cell
suspensions of enzymatically digested 4 week transgenic and nontransgenic thymi
were analyzed by FACS to determine the proportion of TECs to thymocytes. While the
thymus is comprised mostly of thymocytes, K5.CyclinD1 transgenic mice exhibited an
increase in the percentage of MHC-expressing TECs compared to nontransgenic
littermates (Figure 5 A-C). In addition, the absolute number of cells in the TEC
population of K5.CyclinD1 thymus was increased compared to nontransgenic
littermates (Figure 5D). Thus, the overexpression of CyclinD1 in the epithelial
compartment results in an expansion in the overall number of cells in the TEC
compartment providing an expanded microenvironment capable of supporting
thymocyte development.
TECs and thymocytes participate in an active crosstalk required for development
and maintenance of both cell types. In order to determine whether expression of the
K5.CyclinD1 transgene altered thymocyte development, we analyzed the frequency of
the major thymocyte subsets defined by CD4 and CD8
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Figure 5. Increased percentage and number of TECs in 4 week old K5.D1 thymi.
(A,B) Representative FACS plots from (A) control (n=3 mice) and (B) K5.D1 (n=3
thymi). (C) The percent of TECs is higher in K5.D1 compared to controls. D. The
absolute cell number of TECs is higher in K5.D1 compared to controls.
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expression. As shown in Figure 6, similar percentages of the major thymocyte subsets
were found in transgenic mice and nontransgenic littermates (Figure 6 A-C). However,
the absolute number of cells in each thymocyte subset was much greater in the
K5.CyclinD1 thymi compared to nontransgenic littermates (Figure 6D). The increased
cellularity in the DN thymocyte progenitor subset supports the notion that the expanded
epithelial compartment in K5.CyclinD1 transgenic mice supports a greater number of
developing thymocytes through the expansion of available microenvironmental niches
for thymocyte precursors.
Although the specificity of the K5 promoter predicts restricted expression of the
transgene to the epithelial compartment, we wanted to verify the fidelity of our model
and confirm that expression was restricted to TECs and absent in hematopoietic cells.
To test this, single cell suspensions from enzyme-dissociated 6 week transgenic and
nontransgenic thymi were sorted into TEC (CD45-MHC class II+) and thymocyte
(CD45+MHC class II-) populations. RNA was recovered from sorted cells, and qRTPCR was performed to analyze the expression levels of transgenic and endogenous
Cyclin D1 (Figure 7). The data obtained confirmed that K5.CyclinD1 expression is
restricted to the TEC compartment in transgenic mice, and is not expressed in the
CD45+ thymocyte compartment. Furthermore, endogenous mouse Cyclin D1
expression is not affected by the expression of the K5.CyclinD1 transgene.
Analysis of naïve and memory T cell distribution in CD4+ spleen cells
Although thymocyte cellularity is increased by ~3 fold in young (4-6 week)
K5.CyclinD1 mice, the number of splenic cells was not substantially increased (Figure
3). The cells in the spleen consist of B cells, T cells and myeloid cells. With respect to T
cells, the spleen houses CD4+ helper and CD8+ cytotoxic T cells, and each type is
comprised of a naïve and memory/activated subset. Previous analyses of the spleen
did not include an examination of splenic populations, nor were the naïve and
memory/activated subsets analyzed. We hypothesized that an increase in thymopoiesis
could result in an increase in naïve peripheral T cells that would not be reflected by
looking at peripheral T cell
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Figure 6. Percent and number of thymocyte subsets in 4 week old K5.D1 thymi. (A,B)
Representative FACS blots of thymocyte subsets in nontransgenic (n=4 mice) and
K5.D1 (n=4 mice). C. Similar percentages of thymocyte subsets in K5.D1 and control
mice. D. The absolute number of thymocytes in each subset is increased in K5.D1
mice.
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Figure 7. K5.D1 transgene expression is restricted to K5.D1 TECs.
qRT-PCR analysis of K5.D1 (A) and endogenous (B) Cyclin D1 expression in FACS
isolated TECs and thymocytes. The data were normalized to α-tubulin. Data show
average values for replicates. The experiment was repeated three times with similar
results.
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compartment as a whole. CD44 and CD62L are generally used to identify naïve and
memory T cell subsets in the peripheral pool (26, 70). Naïve T cells exhibit a
CD44lowCD62Lhigh phenotype, which allows them entry to the secondary lymphoid
organs for interaction with peptide-bearing antigen presenting cells. Memory T cells, on
the other hand, express a CD44highCD62L- phenotype that permits continual circulation
through the periphery. Using these markers, we analyzed the frequency of naïve to
memory CD4 T cells in the spleens of 4 week old K5.CyclinD1 and control littermate
mice. As shown in Figure 8, we found an increase in the percentages of both CD4 and
CD8 T cells in the spleen of K5.D1 mice compared to controls (Figure 8 A,B). After
drawing an electronic gate on the CD4 population, we observed a slight increase in the
percentage of naïve peripheral CD4 T cells in transgenic spleens compared to controls
(Figure 8 C-E). However, there was no difference in the absolute number of naïve T
cells at this age (Figure 8F). These data are limited, however, and do not show how
the contribution of RTEs from the K5.D1 thymus may be affecting the naïve T cell pool,
nor does it determine the frequency of these cells within the population.
Identification of RTEs using the RAG2p-GFP transgenic model system
CD4 T cells that are classified as naïve based on a CD44low and CD62Lhigh
phenotype consist of RTEs as well as MN T cells. To determine if the increased
thymopoiesis in the K5.CyclinD1 thymus alters the distribution of RTEs and MN T cells,
we crossed the K5.CyclinD1 mice with RAG2p-GFP transgenic mice. Prior to analyzing
RTEs in peripheral T cells, we determined if expression of the RAG2p-GFP transgene
altered the thymus or splenic phenotype typical of K5.CyclinD1 mice. For the purpose
of clarity, mice expressing both the K5.Cyclin D1 and RAG2p-GFP transgenes will be
referred to as K5.D1 and mice expressing only the RAG2p-GFP transgene will be
referred to as control for the remainder of this thesis. One factor to consider was that
the RAG2p-GFP mice had been maintained on an FVB background, which could
impact thymus or spleen cellularity. Expression of the K5.CyclinD1 transgene still
resulted in severe thymic hyperplasia at 4 weeks when crossed into the RAG2p-GFP
mouse
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Figure 9. The RAG2p-GFP transgene does not alter the K5.D1 phenotype.
K5.CyclinD1 mice were crossed with RAG2p-GFP mice Thymus weight (A) and
cellularity (B). (C) Ratio of change in cellularity between controls (black bar) and K5.D1
(white bar) on different backgrounds. (D,E). Representative FACS plots of thymocyte
subsets in control (RAG2p-GFP) and K5.D1 (K5.CyclinD1; RAG2p-GFP double
transgenic) mice. An electronic gate was set on CD4 SP thymocytes for analysis of
GFP expression.
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model (Figure 9A,B), suggesting that the K5.CyclinD1 phenotype was unaffected by the
RAG2p-GFP transgene. However, when we compared the cellularity of our K5.D1 mice
on a mixed background to the K5.CyclinD1 transgenic mice on the C57Bl/6J
background, we did find a significant reduction in the cellularity for both control and
K5.D1 thymi at 4 weeks of age (Figure 9B). Nevertheless, the relative increase in
thymus cellularity caused by the K5.CyclinD1 transgene was not affected by the
RAG2p-GFP transgene (Figure 9C). Furthermore, expression of the RAG2p-GFP
transgene did not alter the percentages of thymocyte subsets defined by CD4 and CD8
in either K5.Cyclin D1 mice or their littermate controls (Figure 9D,E). This result is
consistent with earlier work from the Fink lab showing that RAG2p-GFP transgene
expression does not alter proliferation or development of thymocytes (40). Greater
than 90% of CD4 SP thymocytes in RAG2p-GFP mice express high levels of GFP (51).
We found a similar percentage of GFPhigh CD4 SP thymocytes in K5.D1 compared to
controls (Figure 9F,G). Taken together, these data demonstrate co-expression of
RAG2p-GFP and K5.CyclinD1 transgenes did not alter the phenotypes previously
described in the single transgenic lines.
Effect of K5.Cyclin D1 transgene on frequency and number of RTEs in peripheral
CD4 T cells
Thymus export of naïve T cells is required for diversity of the peripheral naïve T
cell pool. Although this process continues throughout life, the number of RTEs in the
peripheral T cell pool is greatly reduced with age as a result of thymus involution. RTEs
and MN T cells make up the naïve T cell population defined by CD44lowCD62Lhigh
expression. Because the K5.CyclinD1 transgene results in a hyperplastic thymus, we
hypothesized that incorporation of RTEs may be enhanced in our mice. On the other
hand, Hale et al reported that RTEs are substantially reduced with age, as the thymus
undergoes involution (51). We chose to investigate the composition of the naïve T cell
population through the use of the RAG2p-GFP transgene, which labels RTEs for
tracking in the periphery. The total naïve CD4 T cell subset was defined by gating on
CD44lowCD62Lhigh cells and subsequently analyzed for GFP expression (Figure 10A-D).
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We found a striking increase in the percentage of GFPhigh and GFPlow cells at the
expense of the GFPneg population in young (4 week) K5.D1 mice compared control
littermates (Figure 10B,D). These data demonstrate an increase in RTEs being
incorporated into the peripheral T cell population (Figure 10B) The increased frequency
of RTEs in K5.D1 spleen cells implies that increased thymopoiesis and RTE output
leads to greater incorporation to the naïve T cell pool. However, we did not observe a
consistent increase in the number of RTEs in K5.D1 mice. This suggests that while
RTEs may be present in the peripheral population, they may not be capable of
surviving when in direct competition with MN T cells. Similar results were found for CD8
T cells (data not shown). These results suggest that peripheral homeostasis is
maintained at four weeks of age in the K5.D1 mice. We also determined the ratio of
CD4 to CD8 T cells in RTEs. There was no difference in the CD4/CD8 RTE ratio
between K5.D1 and control T cells (Figure 10F).
RTE maturation in young K5.CyclinD1 and control mice
One of the unique benefits of the GFP labeling system used in this study is the
ability to distinguish the length of time RTEs have spent outside the thymus. RTEs
have been shown to undergo a maturational program that can be monitored by
increases and loss of certain cell surface markers during the first few weeks in the
periphery. Therefore, the RAG2p-GFP transgene allows us to utilize not only the
expression of GFP as a molecular timer for RTEs, but also to assess their maturation
status in the peripheral T cell pool by expression of a panel of cell surface molecules
(Figure 11). For our purposes, we used the following markers to track RTE maturity:
CD24, CD69, IL-7Rα (CD127) and Qa-2. The expression of cell surface markers CD24
and CD69 are lost as RTEs undergo maturation in the periphery. CD127 and Qa-2
expression are upregulated during RTE maturation. Expression of these markers on
RTEs and MN T cells from K5.D1 and control spleens was analyzed by flow cytometry.
First, we set an electronic gate
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Figure 10 - The distribution of RTEs is altered in 4 week K5.D1 mice. CD4+ T cells
were gated from splenocyte samples, gated to isolated CD44lowCD62Lhigh naive T
cells, and then distributed by GFP intensity (A&B). K5.D1 naive CD4+ T cells consist
of a higher percentage of both GFPhigh and GFPlow RTEs, compared to the control.
However, this altered distribution of GFP+ cells is not seen in the absolute number of
these subsets (C, N=3/group).
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Figure 11. Changes in selected cell surface molecules during RTE maturation. RTE
maturation can be analyzed by the upregulation of IL-7Rα (CD127), CD45RB and Qa2, as well as the loss of CD24 expression.
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on the naïve CD44lowCD62Lhigh subset of CD4+ T cells. This population was further
divided into GFPhigh RTEs, GFPlow RTEs and GFPneg MN T cells. Each of these subsets
was analyzed for expression of a particular maturation marker. The resulting
histograms were overlaid for comparison of each marker in RTEs and MN T cells from
K5.D1 and control mice. At 4 weeks of age, the K5.D1 RTEs exhibited changes similar
to control RTEs in the expression of CD69, CD127 and Qa-2 (Figure 12 A-P). In
contrast, CD24 expression, which is necessary for homeostatic proliferation (42), was
downregulated to a greater extent on GFPhigh RTEs from K5.D1 compared to controls
(Figure 12A-D).
Comparison of thymus and splenic cellularity in K5.D1 and control mice as a
function of age.
A restriction of the T cell repertoire and an increase of memory T cells occur at
the expense of the naïve T cell population in aged mice and humans (71). In order to
determine if preventing thymic involution would impact peripheral homeostasis with
age, K5.D1 mice and control littermates were maintained up to 20 weeks of age. While
20 week mice are in no way old with respect to the normal mouse lifespan, involution is
well underway at this age. Increased thymic weights were observed in K5.D1 mice and
continued to increase with age (Figure 13A). At all time points, the K5.D1 mice
exhibited a significantly higher thymic cellularity than littermate controls (Figure 13B).
Our observations on thymic weights and cellularity agree with a previous report on
studies conducted in mice on an FVB background (65).
Splenic size and cellularity gradually increased with age in K5.D1 mice (Figure
13C,D), but these modest changes were not significant when compared to control
littermates and did not correlate to the relative increase in thymic size we observed in
K5.D1 compared to control mice. This result is particularly important to note, as many
groups have suggested that a peripheral homeostatic mechanism tightly regulates the
absolute number of the peripheral T cell
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Figure 12. Expression of selected maturation markers on GFPhigh, GFPlow and GFPneg
CD4+ naïve T cells from 4 week old control and K5.D1 mice. Electronic gates were set
on CD4+ CD44low CD62Lhigh naïve T cells. These cells were analyzed for GFP
expression level. Representative histograms show expression of CD24 (B-D), CD69 (FH), CD127 (J-L) and Qa-2 (N-P) by GFPhigh, GFPlow and GFPneg naïve T cells from
K5.D1 (blue) and control (green) mice. CD4+ thymocytes (black) were used as positive
controls for CD24, CD69 and CD127 histograms, and isotype controls (red) were
utilized for CD127 and Qa-2 histograms (n=4 mice/group).
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population (27, 72). Furthermore, as RTE output declines with age, clonal expansion of
existing memory T cells occurs to maintain the number of peripheral T cells. Our
thymus and spleen cellularity data taken together suggests that homeostasis is
generally maintained in K5.D1 transgenic mice.
Analysis of RTEs in aged K5.CyclinD1 and control mice
Our studies aimed to determine if a lack of involution directly affects the
distribution of peripheral T cell populations. Therefore, we investigated post-involution
effects on the peripheral T cell population in K5.D1 mice and control littermates. At 20
weeks of age, the K5.D1 transgenic mice displayed an altered distribution that favored
naïve CD4 T cells in the spleen (Figure 14A,B). Investigation of the splenic CD8 T cell
population showed a similar increase of the naïve T cell population (data not shown).
The absolute numbers of memory and naïve T cells showed that there is no change
between the number of cells in the memory populations of control and K5.D1 mice;
rather, K5.D1 mice exhibit a stark increase in the number of naïve T cells present in the
spleen (Figure 14-C,D). This result suggests that the change in distribution of naïve
and memory T cells results from an expansion of the naïve population, and is not due
to a constriction of the size of the memory population.
We then analyzed the distribution of RTEs and MN T cells in naïve CD4 T cells.
In the control mice, the frequency and number of GFPhigh and GFPlow RTEs in the naïve
T cell population decreased with age whereas there was a corresponding increase in
frequency and number of MN T cells. These data are consistent with previous reports
showing that the percentage and number of RTEs declines with age (51). The Fink
group has shown that RTEs are still readily detectable in mice up to two years of age,
though the percentage of RTEs in the splenic T cell population is significantly reduced
(51).
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Therefore, our control data agrees with previous findings.
When we similarly analyzed the K5.D1 mice, we found a notably distinct pattern
of age-related changes in the frequency and number of RTEs. There was a higher
percentage of RTEs and a correspondingly lower percentage of MN T cells in the
peripheral T cell pool of K5.D1 compared to control mice at all ages analyzed (Figure
15). However, there was an inversion in the relative frequency of GFPhigh and GFPlow
RTEs with age. Thus, whereas ~25% of CD4 naïve cells were GFPhigh at 4 and 8
weeks, only ~12% were GFPhigh at 16 and 20 weeks in the K5.D1 spleen. In contrast,
the percentage of K5.D1 GFPlow RTEs was ~40% at 4 weeks but increased to ~50% by
20 weeks of age. Interestingly, however, we found a marked increase in the absolute
number of both GFPhigh and GFPlow RTEs at 20 weeks of age. These data, taken
together with the data on total naïve versus memory T cells (Figure 14) suggest that
the splenic naïve T cell population in K5.D1 mice is significantly expanded. Even
though only a modest increase in splenic cellularity is observed, the naïve T cell
population is substantially increased at the expense of other cell populations in the
spleen.
RTE maturation in aged K5.CyclinD1 and control mice
The quality of thymocytes from regenerated thymi through castration and KGF
treatment has been scrutinized recently in the literature, as neither medullary islet
complexity nor the levels tissue restricted antigens seen in young thymi are restored
with regeneration (64). These observations suggest that T cells produced after thymus
regeneration may be more autoreactive than T cells from young thymi (64). For our
purposes, the data suggest that age-related alterations in the T cell microenvironment
may not be reversed in the regenerated thymus. This consideration points out that we
cannot assume that preventing thymus involution in K5.D1 mice will prevent ageassociated changes in the TEC microenvironment that affect T cell development.
We assessed the maturation status of RTEs from 20 week K5.D1 and littermate
controls by flow cytometric analysis of CD24, CD69, CD127 and Qa-2
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Figure 15. Distribution of GFPhigh, GFPlow, and GFPneg CD4 naïve T cell subsets with
age in K5.D1 and control mice. (A-C) Percentage of GFPhigh (A), GFPlow (B), and
GFPneg (C) populations of naïve T cells with age. (D-F) Absolute number of GFPhigh (D,
*P<0.05), GFPlow (E, *P<0.05 **P<0.001), and GFPneg (F) populations of naïve T cells
with age (n=2+ mice/group).
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expression to determine if age and/or lack of involution affects RTE maturation. Similar
to the data obtained at 4 weeks of age (Figure 12), CD24 expression was
downregulated on K5.D1 GFPhigh RTEs compared to controls (Figure 16A-D). CD69
expression was downregulated on K5.D1 RTEs and MN T cells compared to controls
(Figure 16E-H). This result was unexpected, and might be explained by altered
regulation of S1P1, which regulates CD69 expression and is necessary for T cell
emigration. Alternatively, since CD69 expression is upregulated on TCR activated T
cells, this result could suggest changes in the TCR signaling. Interestingly, CD127
(IL7Ra) expression was elevated at 20 weeks on K5.D1 GFPlow and MN RTEs
compared to controls (Figure 16I-L). CD127 is downregulated upon interaction with IL7, which is one of the main molecules regulating peripheral homeostasis (50, 73). The
increase in CD127 suggests that GFPlow RTEs and MN T cells from the K5.D1
thymus may have a survival advantage compared to GFPhigh T cells. Qa-2 expression
showed little change in the K5.D1 compared to control RTEs and MN T cells (Figure
16M-P). Together, these changes in expression of maturation markers suggest that
the K5.D1 RTEs are undergoing an altered maturation process in the periphery that is
exacerbated with age.
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Figure 16. Expression of selected maturation markers on GFPhigh, GFPlow and GFPneg
CD4 naïve T cells from 20 week old K5.D1 and control mice. Electronic gates were set
on CD4+ CD44lo CD62Lhi naïve T cells. These cells were analyzed for GFP expression
level. Representative histograms show expression of CD24 (B-D), CD69 (F-H), CD127
(J-L) and Qa-2 (N-P) by GFPhigh, GFPlow and GFPneg naïve T cells from K5.D1 (blue)
and control (green) mice. CD4+ thymocytes (black) were used as positive controls for
CD24 and CD69 histograms, and isotype controls (red) were utilized for CD127 and
Qa-2 histograms (control n=4 mice/group, K5.D1 n=6 mice/group).
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CHAPTER 4: DISCUSSION
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Chapter 4: Discussion
The studies of this thesis were designed to address two major hypotheses. The
first was that increased thymopoiesis would increase the number of RTEs incorporated
into the peripheral T cell pool. The second major hypothesis was to determine if
preventing thymic involution would avert the decreased RTE output that occurs with
age and compromises immune responses. In summary, our results show that the
K5.CyclinD1 transgene on different genetic backgrounds resulted in thymic hyperplasia
and promoted thymopoiesis that led to an increase of RTEs in splenic T cells of young
mice and sustained the increase in RTEs up to 20 weeks of age. The greater
incorporation of RTEs in peripheral T cells of K5.D1 mice maintained a relatively high
percentage of naïve T cells and a higher ratio of naïve to memory T cells. Furthermore,
the data suggest that new T cells generated from the K5.CyclinD1 thymus may be
better suited for survival in the peripheral immune population, especially in older mice.
Taken together, our findings suggest that preservation of the TEC population with age
maintains thymopoiesis, leading to greater RTE output and incorporation into the
peripheral T cell pool.
Phenotype in K5.Cyclin D1 mice on a C57Bl/6J background
The hyperplastic thymic phenotype observed in the K5.CyclinD1 transgenic
mouse (65, 66) provides an opportunity to study how prevention of thymus involution
and sustained thymopoiesis affect the contribution of naïve T cells to the peripheral T
cell pool. TECs provide microenvironmental niches that promote thymopoiesis by
providing factors necessary for thymocyte growth, survival and differentiation (74). It
has been shown that an increase in the number of TECs provides more
microenvironmental niches to support greater thymopoiesis (75). We observed an
increase in the K5+K8+K14- (Figure 4) TEC population that harbors TEC precursors.
We also found an increased number of TECs by flow cytometry, confirming that the
expression of the K5.CyclinD1 transgene drives expansion of the TEC population. We
clearly demonstrated that increased thymocyte cellularity is not a result of transgene
expression in thymocytes by qRT-PCR data. Thymus size is has been shown to be
positively regulated by the number of TECs present (76). Therefore, our results support
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the idea that increased percentage of TECs in the thymus promotes expansion of
thymocyte cellularity through an increase in microenvironmental niches necessary for
thymocyte development. However, to prove this premise would require isolation and
functional analysis of TEC progenitors.
Thymus hyperplasia was evident in K5.D1 mice at 4 weeks and increased with
age, however, only minimal expansion in the splenic cellularity occurred. One
explanation for this observation may be that SP thymocytes are not exiting the K5.D1
thymus, and therefore are not able to join the peripheral T cell population. However, at
no point in these studies was a major increase in the percentage of SP thymocytes
observed in the thymus to indicate retention. Furthermore, we observed the proper
loss of CD69 expression, which is regulated by the sphingosine-1-phosphate receptor
in a reciprocal manner (19). S1P1 expression is necessary for thymic emigration, and
the downregulation of the CD69 expression suggests that S1P1 was expressed (18).
GFP+ RTEs were observed in the spleen of K5.D1 mice when crossed to the RAG2pGFP transgene. This confirmed that thymocytes are released from the hyperplastic
K5.Cyclin D1 thymus to the periphery, as the expression of Rag2 is permanently
extinguished during thymopoiesis (40). These data combined suggest no observable
retention of SP thymocytes. In another study investigating thymic hyperplasia,
increases in peripheral T cell population size were also minimal (77), suggesting that
the peripheral homeostasis may act restrictively to control the size of the peripheral
pool in these cases.
Background Influence on thymus size
Determining the effect of background strain on transgenic phenotype was not an
initial aim of our studies, but was a necessary component to our analyses. Because of
limited availability, we crossed the K5.CyclinD1 mice on a C57Bl/6J background to
RAG2p-GFP females on an FVB background. This cross caused the study mice to be
on a 50:50 mixed background, and led to the reduction in thymus size and cellularity.
Others have established that genetic background greatly influences thymus size and
involution (68). C57Bl/6J mice are considered a ‘slow involution’ strain that exhibits a
larger thymus, and therefore, most immunological studies are performed with mice on
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this background (78). We observed a reduction in size upon initial dissection of both
control and K5.D1 thymi, confirming that FVB background genes result in a smaller
thymus size and cellularity, even when expressing the K5.CyclinD1 transgene.
Furthermore, when these data were compared to K5.D1 and control data on the
C57Bl/6J background, the changes in size and cellularity were similar in both K5.D1
and control genotypes, indicating that the background affected both genotypes to the
same extent. FVB mice tend to have smaller thymi and undergo premature involution
compared to age matched C57Bl/6J mice (79) supporting our conclusion that our
results are due to the background genetics and not to RAG2p-GFP expression. Dr.
Pam Fink is providing us with RAG2p-GFP mice on the C57Bl/6J background to
confirm this conclusion as well as for future studies as described below.
Frequency and maturation of RTEs in young K5.Cyclin D1 and control CD4 T
cells
The naïve T cell compartment is robust at a young age in normal mice, and
contains a high percentage of naïve T cells. Our observations in young K5.D1 mice
suggest that the transgene may not yet have an impact on the distribution of the
peripheral T cell subsets. There was a minimal increase in the percentage of naïve
splenic T cells, but no increase in the number of naïve splenic T cells in the K5.D1
mice, which suggests that peripheral homeostasis is maintained in these mice at 4
weeks of age. Expression of the K5.D1 transgene did result in an increased
incorporation of RTEs into the CD4 naïve T cell compartment, supporting increased
released of RTEs from the thymus. These findings were unexpected, as normal RTEs
do not compete as efficiently with MN T cells in the periphery (21). Other groups
interested in thymic size and rebound have also seen an increase in RTEs when the
thymus is regenerated by administration of exogenous growth factors (77, 80). K5.D1
RTEs may posses a selective advantage compared to control counterparts. This
premise can be tested in adoptive transfer experiments described in a later section.
Additionally, our cohort was too small in this study, and the 4 week age data suggested
that the peripheral T cell population may be impacted more significantly than the power
of our study was able to describe. Further investigation with larger cohorts will be
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performed to determine more precisely how the thymus hyperplasia in K5.CyclinD1
transgenic mice affects the number and frequency of RTEs in the peripheral T cell
population.
In order to understand how transgene expression affected extra-thymic T cell
maturation, we investigated the maturation status of newly exported T cells from the
K5.D1 transgenic thymus. The results showed little difference in maturation markers
between the K5.D1 RTEs and those from control littermates at 4 weeks of age, with the
exception of CD24 expression. CD24 is necessary for homeostatic proliferation and
transition to memory T cell type, but is not necessary for survival (42). CD24
expression was downregulated in K5.D1 GFPhigh RTEs relative to control RTEs,
whereas CD24 expression in the GFPneg MN T cells is comparable in K5.D1 and
control splenic CD4 T cells. While functional consequences of CD24 expression on
RTEs have not been specifically elucidated, the lower expression level of CD24 K5.D1
GFPhigh RTEs suggests that these cells may have defective homeostatic proliferation in
a lymphopenic environment. Future studies will analyze phenotypic RTE maturation
using additional maturation markers. The cell surface molecules CD28, CD3 and
CD45RB have been used to monitor RTE maturation (28), and may provide more
information about the maturation of K5.D1 RTEs. In addition, functional analyses such
as cytokine production and antigen-induced proliferation, will be performed to
determine if thymocyte development in the K5.D1 thymus alters the kinetics and/or
degree of RTE maturation
Analysis of the naïve T cell subsets and RTE contribution in aged K5.CyclinD1
and control mice
The second aim of this study was to determine how aging affected thymopoiesis
in the non-involuting K5.D1 model. The data presented show that the composition of
the naïve T cell population is altered when thymus involution is prevented. In
nontransgenic mice age-related thymus involution results in a reduction of RTEs that
diminishes the number and proportion of naïve peripheral T cells population and results
in clonal expansion of the T cells to maintain total peripheral T cell numbers (56). The
total number of splenic cells was not significantly affected in young K5.D1 mice at 20
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weeks of age, but there was a very apparent shift favoring the percentage of naïve to
memory/activated T cells in K5.D1 compared to control mice. This result attests to the
idea that continued thymic output of new T cells from the K5.D1 thymus can impede
age-associated reductions in RTEs in the naive peripheral T cell population. At 20
weeks of age, the number of CD4 and CD8 naïve T cells was increased in the K5.D1
spleen; however, the number CD4 and CD8 memory/activated T cells was not
significantly different from control. This suggests that the increased numbers of RTEs
and naïve T cells present in the K5.D1 mouse model does not actually restrict clonal
expansion of the memory population. Instead, the change in distribution of naïve to
memory CD4 T cells results from the greatly increased numbers of RTEs and MN T
cells present in the periphery – absolute numbers of total naive T cells at 20 weeks
were four fold higher than that of naïve numbers at 4 weeks of age. Therefore, we
suggest that the K5.D1 mouse model overwhelms the peripheral homeostatic
mechanism by the release of sustained and increased output of RTEs to the periphery.
It has been reported that RTEs are at a competitive disadvantage compared to
MN T cells for incorporation into the peripheral T cell pool of lymphoreplete mice (21).
Interestingly, phenotypic analysis of differentiation markers suggested that RTE
maturation is altered in K5.D1 mice, which may provide an explanation for the increase
in number of splenic CD4 naïve T cells. Those cells that recently emigrated from the
thymus in 20 week mice continued to express CD24 on RTEs at a lower level than their
control littermates. This result is consistent with the downregulation of CD24 seen at 4
weeks, and suggests an age-associated downregulation of this molecule on RTEs.
Because CD24 is necessary for conversion of naïve T cells to the memory T cell type
(42), normal memory T cell expansion may be inhibited, which would agree with the
altered distribution of naïve:memory T cells seen at 20 weeks of age. Furthermore,
K5.D1 RTEs displayed increased expression of IL-7Rα (CD127) during maturation in
the periphery. IL-7 is one of the few known regulators of peripheral T cell homeostasis,
and the increase of IL-7Rα expression in K5.D1 naïve T cells may impart a selective
survival advantage. Recent studies suggest that TCR engagement during
thymopoiesis is integral in determining the level of expression of IL-7Rα on mature T
cells, which impacts their survival potential (81). In addition, IL-7 transgenic mice have
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an increased number of mature T cells (82), and only T cells with appropriate levels of
IL-7Rα expression survive in the periphery (81). Therefore, the naïve T cells in older
K5.D1 mice may be expressing higher levels of IL-7Rα and increasing their survival
potential as a consequence of enhanced TCR signaling in thymocytes perhaps induced
by engagement with self peptides presented on TECs. A corollary to this hypothesis is
that age-related changes in the array of self-peptide/MHC complexes presented to
thymocytes by K5.D1 TECs and/or their ability to present self-peptides may enhance
TCR mediated signaling. However, regardless of the specific explanation, the
increased expression of IL-7Rα may allow K5.D1 RTEs to compete more effectively
with MN T cells for incorporation into the peripheral T cell pool. This premise will be
tested in future experiments summarized below.
Age-related changes in the frequency of naïve T cells in K5.CyclinD1 and control
mice
The expansion of the naïve T cell population observed in the K5.D1 periphery
was largely due to the increased incorporation of RTEs. However, the frequency of
GFPhigh RTEs dramatically dropped with age in K5.D1 mice, while the RTElow and
RTEneg frequencies increased (Figure 15). We considered the possibility that this
pattern may be due to retention of RTEs in aging K5.D1 transgenic thymi. However,
this was not the case, as total cell number for the RTEhigh subset dramatically rose with
age and there was no increase in the percentage of SP thymocytes in 5 month old
mice.
Overall, every RTE population expanded in total cell number the K5.D1
transgenic mouse. This result suggests a few possible circumstances. The first
explanation for the results we’ve observed is that RTEs may be proliferating at a faster
rate in the K5.D1 periphery. This is most likely not the case, as we showed that the
transgene was restricted to the TEC compartment and not present in developing
thymocytes (Figure 7). Additionally, utilization of the time sensitive, and proliferation
sensitive GFP label precludes any proliferative expansion of the GFPhigh and GFPlow
subsets without these cells losing GFP intensity (40). However, there may still be some
type of change in proliferative capability of peripheral T cells in the K5.D1 transgenic
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mice that has been conferred by the transgene expressing TECs. This hypothesis
should be tested through the use of a proliferation assay coupled with GFP transgenic
expression to determine if the GFPhigh and GFPlow RTE subsets are proliferating at an
increased rate in K5.D1 mice.
The increased cellularity of GFPlow and GFPneg naïve T cells could be a
consequence of a survival advantage perhaps as suggested above, due to increased
IL-7Rα expression. If this were the case, it would explain why our results show
increases in the GFPlow RTE population with time – persisting GFPhigh cells in the
periphery would cause an expansion of the GFPlow and MN T cell subsets as they
matured. There are two known limiting factors involved in peripheral T cell
homeostasis: availability of MHC molecules for TCR engagement and the availability
of the cytokine IL-7 (26). However, while the increase in receptor expression on the
K5.D1 naïve T cell subsets may allow them a better chance of survival in periphery, it
doesn’t solve the predicament of the limited amount of IL-7 cytokine released by
stromal cells. Nevertheless, the hypothesis that enhanced survival improves the ability
of K5.D1 RTEs to become incorporated into the peripheral T cell pool can be tested in
a competitive adoptive transfer assay. An equal ratio of CD45.1+ K5.D1 RTEs would be
mixed with CD45.2 control RTEs and injected into an irradiated CD45.1+/CD45.2+
recipient (Figure 17). At various times after the adoptive transfer groups of mice will be
sacrificed and the splenic T cells analyzed for the contribution of CD45.1 and CD45.2
RTEs in the peripheral T cell pool. This experiment could also be performed with RTEs
expressing high versus low levels of IL-7Rα.
The other possible explanation for the observed results in K5.D1 mice is that the
thymus releases such a vast amount of RTEs to the peripherally that the naïve
compartment is inundated with T cells, overwhelming homeostasis and causing
increased cell numbers in every T cell subset. There may be no increased survival
potential in K5.D1 RTEs, and our observations could stem from an overwhelming
number of RTEs released to the periphery. RTEs can persist for weeks in the
periphery without any interaction, while our GFP label is only detectable for three
weeks (83). There may be no selective advantage to the RTEs being produced, and
the results observed are simply an affect of expanding the peripheral T cell population.
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Figure 17. Proposed adoptive transfer experimental setup. K5.CyclinD1 mice will be
bred to RAG2p-GFP mice bearing the congenically marked CD45.1 RTEs. RTEs from
this cross will be added with control RAG2p-GFP CD45.2 RTEs at a 1:1 ratio to
heterozygous (CD45.1,CD45.2) irradiated recipients to determine survival potential.
Transferred RTEs will be analyzed 24 hours, 1 week and 3 weeks post transfer.
and allowing RTEs from the thymus to lose signal and die in the periphery.
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However, previous work analyzing how multiple transplanted thymi affected the
peripheral T cell population showed that even with an expanded number of T cells
being produced, peripheral homeostasis was capable of controlling T cell number in the
periphery, and only a small increase in peripheral T cell size was observed (24), and
this agrees with our minimal increase in total splenic cellularity date in the K5.D1 at 20
weeks of age. Therefore, this hypothesis should be tested through a cell death assay
coupled with the GFP transgenic expression to determine if there is an increase in cell
death in the GFPlow and MN subsets. The investigation of IL-7 in secondary lymphoid
organs and RTE adoptive transfers should also be performed to rule out other
possibilities for the observed results.
Conclusions and Future Aims
In conclusion, the studies presented in this thesis demonstrate that increased
thymopoiesis results in a greater proportion of RTEs in the peripheral T cell pool in
young mice and prevents age-associated decrease in RTEs. The altered distribution of
naïve versus memory peripheral T cell subsets, combined with the continued
production of RTEs suggest that the diversity of the peripheral TCR repertoire may be
sustained or even enhanced. This is an important advantage since a diverse TCR
repertoire is necessary for successful immune responses to new antigens.
Our study did not directly analyze the number of cells/day that emigrate from the
thymus of K5.D1 and control mice. Prior studies have directly quantified the number of
thymic emigrants by injecting FITC directly into the thymus and counting the number of
FITC labeled T cells in peripheral lymphoid organs at 24 hours. We also plan to directly
analyze the TCR diversity of naïve T cells in the periphery of K5.D1 and control mice at
various ages. This can be accomplished by utilizing CDR3 length spectratyping .
Another future goal of this project is to determine whether the increase of RTEs in the
K5.D1 mouse confers greater immune responsiveness to new antigens, and future
aging studies will include mice up to one year in age. The K5.CyclinD1 mouse model is
a valuable asset for studies to discern how thymus hyperplasia and lack of involution
affect the composition and function of the peripheral T cell pool.
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